Antimalarial Adherence Linked to Lower Hospitalization Risk in RA and SLE - Infectious Disease Advisor

AI Briefing

• – Antimalarial medications have been shown to reduce hospitalization risk in patients with rheumatoid arthritis and systemic lupus erythematosus by improving disease activity and preventing complications.
• – Studies have found that consistent adherence to antimalarial treatment can lead to significant reductions in hospitalization rates, particularly among those with severe disease activity.
• – The findings suggest that antimalarial therapy should be considered as a valuable adjunct to conventional treatments for managing these chronic autoimmune diseases.